Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13031
Title: Transient hypoxaemia during neutrophil recovery in febrile patients.
Austin Authors: White, K;Cebon, Jonathan S 
Affiliation: Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Austin Hospital, Heidelberg, Australia
Issue Date: 22-Apr-1995
Publication information: Lancet (london, England); 345(8956): 1022-4
Abstract: In previous anecdotal reports, treatment with granulocyte colony-stimulating factor has been associated with pulmonary toxicity. In 35 consecutive admissions for chemotherapy-induced febrile neutropenia, transient hypoxia occurred in 12. 10 of the 12 followed treatment with filgrastim to induce neutrophil recovery. There was no consistent association with cytotoxic regimen.
Gov't Doc #: 7536871
URI: http://ahro.austin.org.au/austinjspui/handle/1/13031
URL: https://pubmed.ncbi.nlm.nih.gov/7536871
Type: Journal Article
Subjects: Adolescent
Adult
Anoxia.etiology
Fever.complications.drug therapy
Granulocyte Colony-Stimulating Factor.therapeutic use
Humans
Male
Middle Aged
Neutropenia.complications.drug therapy
Recombinant Proteins.therapeutic use
Appears in Collections:Journal articles

Show full item record

Page view(s)

2
checked on Dec 2, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.